MBP and Increased total eosinophil count: Skewing the type 2 immune response towards a more pronounced type 1 response by administering IL-12 significantly reduced IgG1 and IgE levels, eosinophilia as well as MBP levels and lessened lung pathology in the TPE mouse model (76).